1Sweadner KJ,Rael E. The FXYD gene family of small ion transport regulators or channels:cDNA sequence,protein signature sequence,and expression[J].Genomics,2000,(01):41-56.doi:10.1006/geno.2000.6274.
2Li C,Gresdidier A,Crambert G. Structural and functional interaction sites between Na,K-ATPase and FXYD proteins[J].Journal of Biological Chemistry,2004,(37):38895-38902.doi:10.1074/jbc.M406697200.
4Iacobuzio-Donahue CA,Maitra A,Olin M. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays[J].American Journal of Pathology,2003,(04):1151-1162.
5Friess H,Ding J,Kleeff J. Microarray-based identification of differentially expressed growth-and metastasis-associated genes in pancreatic cancer[J].Cellular and Molecular Life Sciences,2003,(06):1180-1199.
6Kayed H,Kleeff J,Kolb A. FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth[J].International Journal of Cancer,2006,(01):43-54.doi:10.1002/ijc.21257.
7Izumi T,Oda Y,Hasegawa T. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor[J].Mad Pathol,2006,(06):820-831.
8Kyzas PA,Stefanou D,Batistatou A. Dysadherin expression in head and neck sqanmous cell carcinoma:association with lymphangiogenesis and prognostic significance[J].American Journal of Surgical Pathology,2006,(02):185-193.doi:10.1097/01.pas.0000178090.54147.f8.
9Shimamura T,Yasuda J,Ino Y. Dysadhcrin expression facilitates cell motility and metastatic potential of human pancreaticcancer cells[J].Cancer Research,2004,(19):6989-6995.doi:10.1158/0008-5472.CAN-04-1166.
10Yamaguchi F,Yamaguchi K,Tai Y. Molecular cloning and characterization of a novel phospholemman-like protein from rat hippocampus[J].Brain Research Molecular Brain Research,2001,(1-2):189-192.doi:10.1016/S0169-328X(00)00213-8.
2Huh SJ, Chen YL, Friedman SL, et al. KLF6 gene and early melanoma development in a collagen I-Rich extracellular environment[J]. J Natl Cancer Inst, 2010, 102(15):1131- 1147.
3Salma J, McDermott JC. Suppression of a MEF2-KLF6 sur- vival pathway by PKA signaling promotes apoptosis in em- blyonic hippocampal neurons[J]. J Neurosci, 2012, 32(8): 2790-2803.
4Reeves HL, Narla G, Ogunbiyi O, et al. Kmppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer[J]. Gastroenterology, 2004, 126(4):1090- 1103.
5Grisanzio C, Werner L, Takeda D, et al. Genetic and func- tional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis[J]. PNAS, 2012, 109(28):11252-11257.
6Okuda J, Hayashi N, Okamoto M, et al. Translocation of pseudomonas aeruginosa from the intestinal tract is mediated by the binding of ExoS to an Na, K-ATPase regulator, FXYD3[J]. Infect Immun, 2010, 78(11):4511-4522.
